- Home
- AVIR vs INSE Comparison
AVIR vs INSE Comparison
Compare AVIR & INSE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AVIR
- INSE
- Stock Information
- Founded
- AVIR 2012
- INSE 2002
- Country
- AVIR United States
- INSE United States
- Employees
- AVIR N/A
- INSE N/A
- Industry
- AVIR Medicinal Chemicals and Botanical Products
- INSE Computer Software: Prepackaged Software
- Sector
- AVIR Health Care
- INSE Technology
- Exchange
- AVIR Nasdaq
- INSE Nasdaq
- Market Cap
- AVIR 290.4M
- INSE 233.4M
- IPO Year
- AVIR 2020
- INSE N/A
- Fundamental
- Price
- AVIR $3.25
- INSE $8.00
- Analyst Decision
- AVIR Hold
- INSE Buy
- Analyst Count
- AVIR 1
- INSE 6
- Target Price
- AVIR $6.00
- INSE $13.50
- AVG Volume (30 Days)
- AVIR 353.8K
- INSE 97.8K
- Earning Date
- AVIR 11-12-2025
- INSE 11-05-2025
- Dividend Yield
- AVIR N/A
- INSE N/A
- EPS Growth
- AVIR N/A
- INSE N/A
- EPS
- AVIR N/A
- INSE 1.93
- Revenue
- AVIR N/A
- INSE $309,900,000.00
- Revenue This Year
- AVIR N/A
- INSE $4.53
- Revenue Next Year
- AVIR N/A
- INSE N/A
- P/E Ratio
- AVIR N/A
- INSE $4.43
- Revenue Growth
- AVIR N/A
- INSE 4.66
- 52 Week Low
- AVIR $2.46
- INSE $6.51
- 52 Week High
- AVIR $4.02
- INSE $11.61
- Technical
- Relative Strength Index (RSI)
- AVIR 55.27
- INSE 46.79
- Support Level
- AVIR $3.18
- INSE $7.42
- Resistance Level
- AVIR $3.27
- INSE $8.84
- Average True Range (ATR)
- AVIR 0.09
- INSE 0.38
- MACD
- AVIR 0.00
- INSE 0.07
- Stochastic Oscillator
- AVIR 60.00
- INSE 42.54
About AVIR Atea Pharmaceuticals Inc.
Atea Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on discovering, developing, and commercializing antiviral therapeutics to improve the lives of patients suffering from serious viral infections. The company is developing its product candidate, bemnifosbuvir, for the treatment of COVID-19, the disease caused by infection with Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and its variants and also developing bemnifosbuvir in combination with ruzasvir for the treatment of Hepatitis C (HCV).
About INSE Inspired Entertainment Inc.
Inspired Entertainment Inc is a gaming technology company based in the United States. Its core business involves the development of Virtual Sports and Server-Based Gaming systems with associated terminals and digital content to regulate betting, gaming, and lottery operators around the world. It operates through four segments, namely Gaming, Virtual Sports, Interactive, and Leisure. The company generates maximum revenue from the Gaming segment. Its Gaming segment supplies gaming terminals as well as gaming software and games for the terminals provided to betting offices, casinos, gaming halls, and high street adult gaming centers. Geographically, it derives a majority of revenue from the UK.